CHRISTOPHER PATE: Open Payments
NPI 1740736263 · TIFTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$704 in 31 payments from 13 companies in 2025. Trend: 2023 $963 · 2024 $557 · 2025 $704
Food & beverage: $704
| Company | Payments | Amount |
|---|---|---|
| Antares Pharma, Inc. | 5 | $121 |
| TOLMAR, INC. | 4 | $110 |
| Sumitomo Pharma America, Inc. | 4 | $74 |
| Medtronic, Inc. | 3 | $74 |
| Endo USA, Inc. | 2 | $54 |
| ABBVIE INC. | 2 | $52 |
| Ferring Pharmaceuticals Inc. | 3 | $42 |
| PFIZER INC. | 2 | $42 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $41 |
| UROGEN PHARMA, INC. | 1 | $32 |
Products named: XYOSTED, JATENZO, GEMTESA, XTANDI, XIAFLEX, ADSTILADRIN, JOURNAVX, ALTAVIVA.
Industry payments across GA — which companies pay providers there.
